Thomas L. Petty Aspen Lung Conference

66th Annual Meeting | June 4-7, 2024


66th Annual Meeting | June 4-7, 2024

Pulmonary Fibrosis – Focusing on the Future

Elizabeth Redente, Ph.D., Chair
David Schwartz, M.D., Co-Chair

The Gant Conference Center
Aspen, Colorado

In-person or virtual live streaming format is available.
Registered virtual attendees can access live sessions.


The prevalence of fibrosis is increasing, in part caused by an aging population, advances in diagnostic tools and exposure to infectious agents and other environmental factors that impact pathogenesis. Understanding the effect of these factors on the clinical manifestation of different fibrosis pathologies and pursing novel advances in lung regeneration after scarring will have a significant impact on lung health. The 2024 Thomas L. Petty Aspen Lung Conference will focus on the future of lung fibrosis by integrating clinical unmet needs with the biology of lung fibrosis and fibrosis resolution.

To address this goal, the conference will integrate basic, translational, and clinical approaches to:

  1. Understand the common threads of usual interstitial pneumonias (UIPs).
  2. Explore the dynamic cellular and structural biology associated with lung fibrosis. 
  3. Consider novel approaches to the diagnosis of early lung fibrosis and disease progression.
  4. Integrate advances in genetic discoveries to drive basic, translational and clinical research.
  5. Discuss transformational interventions for treatment of early and established lung fibrosis.  

The conference will provide an international forum that brings together leading basic, translational, and clinical researchers and welcomes trainees across the fields of pulmonary medicine, genetics, cell biology and immunology with the goal of identifying shared interests that will lead to more productive research and ultimately improve lung health.

Finally, the varied scientific themes and therapeutic strategies that emerge during the conference will be reconciled in the Conference Summary presented by Dr. Patricia Sime (Virginia Commonwealth University). 

Four Fellow Travel Awards will be awarded to fellows whose abstracts have been accepted for podium presentations. 


Local/Regional/National/International Physicians/Clinicians (adult and pediatric)/Research Physician-Scientists in Pulmonary Sciences, Critical Care and Sleep Medicine/Research Scientists (PhD) in lung injury/Primary Care Physicians/General Medicine Physicians/Public Health.

 

NOTE: If the number of people wishing to attend the Conference exceeds the capacity of The Gant Conference Center, those with accepted abstracts (and, in the case of junior presenters, their mentors) will be given preference for “in person” attendance, with a remote option for those who are unable to attend “in person” or a combination of remote and in person.

Health, Safety and Behavior Guidelines

 

The Thomas L. Petty Aspen Lung Conference (TLPALC) believes that everyone deserves to be respected and safe whenever participating in the Conference and its activities.  In accordance with CDC, NIH and TLPALC guidelines and legal requirements, please carefully review the following terms and conditions and acknowledge your agreement by completing and submitting the Waiver of Liability linked below.

 

COVID-19

 

The TLPALC will follow the requirements specified by the Centers for Disease and Prevention to prevent the spread of COVID-19 during the Conference and its associated activities.

Though not a requirement, we encourage attendees to be vaccinated and wear a mask when in close proximity to others. Additionally, we urge all attendees to perform a daily COVID-19 self-assessment as defined by the CDC: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

Travel information and requirements as required by the CDC can be found at: https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html

Please check back with us regularly as TLPALC may revise safety protocols based on the local public health requirements, current conditions, legal requirements, and recommendations in place at the time of the Conference.

 

Inappropriate Behavior

 

The 2024 Aspen Lung Conference is in part funded by a grant from the NIH to National Jewish Health.  National Jewish Health (NJH) is committed to providing a safe environment, free of harassment and discrimination. Participants at the TLPALC must comply with NJH’s Workplace Behavior Policy and Code of Conduct. Please review the information provided in the Safety Planwhich describes our non-discrimination and anti-harassment policies, as well as how to report any violations of these policies, how to make a complaint, and how any complaints will be resolved.

 

Waiver of Liability

 

Read, complete and submit the Waiver of Liability Form.

The 2024 Aspen Lung Conference is in part funded by a grant from the NIH to National Jewish Health.  National Jewish Health (NJH) is committed to providing a safe environment, free of harassment and discrimination. Participants in NJH programs and
 activities (including this event) must comply with NJH’s Workplace Behavior Policy and Code of Conduct. Please review the following information regarding NJH’s non-discrimination and anti-harassment policies, as well as how to report
 any violations of these policies, how to make a complaint, and how any complaints will be resolved.


NJH can provide supportive measures and other resources with or without the filing of a formal complaint by calling the confidential Compliance Hotline, 1-844-369-5635 or reporting a complaint at www.njhealth.ethicspoint.com. In an emergency, please dial 911. Non-emergency reports to security can be made to the NJH Security Office for on-campus incidents (303-398-1776) or to the local police department where the incident occurred.



National Jewish Health Notice of Non-Discrimination, Anti-Harassment and Non-Retaliation



Fair and equitable treatment of all employees, patients, and other persons is critical to fulfilling the mission and goals of NJH. Patients are to be treated without regard to gender, race, color, sexual orientation, religion, disability, age, marital
 status, or national origin. NJH hires, recruits, trains, promotes, assigns, transfers, lays off and terminates employees based on such factors as their own ability, achievement, experience, and conduct without regard to gender, race, color, sexual
 orientation, gender identity, religion, disability, age, marital status, or national origin. NJH does not discriminate against any individual with a disability with respect to any offer or term or condition of employment. We will make reasonable accommodations
 to the known physical or mental limitations of otherwise qualified individuals with disabilities.








Every employee has the right to work in an environment free of unlawful harassment, abusive, threatening or intimidating behavior and discriminatory retaliation. Unlawful employment discrimination and harassment based on gender, race, color, sexual orientation, religion, disability, age, marital status, or national origin is unacceptable and, therefore, prohibited. NJH has a zero tolerance policy for unlawful harassment. Degrading, derogatory, humiliating remarks, comments, jokes and slurs are considered inappropriate behavior and are not permitted at NJH.




Unlawful sexual harassment is a violation of NJH policy and prohibited. This prohibition includes unwelcome sexual advances or requests for sexual favors and other verbal or physical conduct of a sexual nature which occur when: (1) submission to such conduct is made either explicitly or implicitly a term or condition of an individual’s employment; (2) submission to or rejection of such conduct by an individual is used as the basis for employment decisions affecting the individual; or (3) such conduct has the purpose or effect of unreasonably interfering with an individual’s work performance or creates an offensive, intimidating or threatening work environment. Sexual advances, requests for sexual favors or sexual propositions are examples of potentially harassing behavior.



Some examples of harassing behaviors may be:










  • Unwelcome sexual advances or requests for sexual favors;
  • Unwelcome comments or behavior, including but not limited to drawings, written statements, social media posts, or verbal statements, related to an individual’s race, ethnicity, color, national origin, sex, disability, religion, age, gender, gender identity, disability, height, marital status, political persuasion, sexual orientation, veteran status, or weight
  • Unwelcome teasing, joking, or flirting based on actual or perceived gender identity, gender expression, or sexual identity/orientation.





Any employee or third party who believes he or she has been discriminated against or harassed is encouraged to report the incident(s) to either National Jewish Health’s Human Resource’s Office or the Compliance Office.  National Jewish Health will respond promptly, including by offering supportive measures, informing parties about the available complaint and investigation processes, and taking reasonable care to prevent and promptly correct discrimination or harassment.

National Jewish Health is committed to conducting prompt and equitable investigations and will appropriately address violations of policy. Upon completion of an investigation, anyone found to have engaged in acts of harassment, discrimination or retaliation will be promptly disciplined. If circumstances warrant, discipline for employees may include corrective action up to termination. 

Any person may report discrimination, harassment or retaliation in person, by mail, by telephone, or on-line at the contact information listed below. Reports may be made at any time (including during non-business hours) by using the telephone number and
 online reporting form.



National Jewish Health, Human Resources and/or Compliance Office, 1400 Jackson Street, Denver, CO 80206, 1-844-369-5635, or www.njhealth.ethicspoint.com.

Questions about National Jewish Health’s non-discrimination and anti-harassment policies may be referred to the National Jewish Health Human Resources Department at (303)-398-1038 or HR@njhealth.org.

Individuals may also notify NIH (https://public.era.nih.gov/shape/public/notificationForm.eraor (301) 480-6701) or file a complaint with HHS OCR at the address below about concerns of harassment, including sexual harassment, discrimination, and other forms of inappropriate conduct at NIH-supported conferences.

U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201

1-800-368-1019, 800-537-7697 (TDD)

http://www.hhs.gov/ocr/office/file/index.html

Filing a complaint with National Jewish Health is not required before filing a complaint of discrimination with HHS OCR, and seeking assistance from National Jewish Health in no way prohibits filing complaints with HHS OCR

Printable version of the 2024 Safety Plan.

Exhibit at the Aspen Lung Conference

Meet face-to-face with leading clinicians and translational and basic scientists to exchange ideas related to the future of pulmonary fibrosis research.

Share your latest updates, products, services and equipment pertinent to the field of pulmonary fibrosis.

Build your contacts and relationships with leading medical professionals in the field of fibrosis. 

For more information contact: Jeanne.Cleary@cuanschutz.edu

 


 

We look forward to your participation in the Thomas L. Petty Aspen Lung Conference, 66th Annual Meeting and to a combination of outstanding science and great fun. We hope that you and your colleagues can join us.

Elizabeth Redente, Ph.D., Chair
David Schwartz, M.D., Co-Chair

 


Save the Date!

2025 Annual Meeting

Exploring the Void: Advances in Parenchymal Destruction in Emphysema

June 3-6, 2025

 

Registration for the 66th annual Thomas L. Petty Aspen Lung Conference will open soon.

 


 

Americans with Disabilities Act Statement: Please indicate if you have any need for auxiliary aids or special assistance services.

 


 

CMS Login